The primary outcome occurred in fewer patients in the combined treatment. Combined vs double placebo. Combined: 4.1%. Double-placebo: 5.8%. HR 0.69 (95% CI, 0.50 to 0.97) The incidence of hypotension or dizziness was higher in groups that received the polypill than in their respective placebo groups..